Beryl Drugs Ltd — Important, 08-04-2026: Company Update

Beryl Drugs has submitted a compliance certificate for the year ended March 31, 2026, confirming its adherence to share registry requirements. The certificate states that there were no equity share transfers recorded during this period. Additionally, no new share certificates were issued for activities like sub-division, consolidation, or renewal. This filing is a routine update, assuring investors about the company's diligent management of shareholder records and compliance with administrative obligations.